Alkermes
ALKS
#2321
Rank
ยฃ5.92 B
Marketcap
ยฃ35.24
Share price
-1.43%
Change (1 day)
60.45%
Change (1 year)

EPS for Alkermes (ALKS)

EPS in 2026 (TTM): -ยฃ0.003887

According to Alkermes's latest financial reports the company's current EPS (TTM) is -ยฃ0.0000000000. In 2025 the company made an earnings per share (EPS) of ยฃ1.12 a decrease over its 2024 EPS that were of ยฃ1.70.

EPS history for Alkermes from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.003887-100.35%
2025ยฃ1.12-34.08%
2024ยฃ1.703.72%
2023ยฃ1.64-323.96%
2022-ยฃ0.73220%
2021-ยฃ0.23-57.19%
2020-ยฃ0.53-44.38%
2019-ยฃ0.96
2017-ยฃ0.79-24.82%
2016-ยฃ1.05-9.87%
2015-ยฃ1.16660%
2014-ยฃ0.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.10-12,033,301,387,828,043,776.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ4.01-9,457,550,908,645,464,064.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ0.54-1,279,021,170,502,529,280.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.51-3,567,802,533,542,781,440.00%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
ยฃ3.45-8,142,500,972,776,666,112.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ5.43-12,826,240,470,391,560,192.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Acorda Therapeutics
ACOR
-ยฃ38.40 90,630,359,278,848,262,144.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.34-810,647,220,741,040,000.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel